PPS Travel Award

To further its goal of supporting collaboration, research and training in Pulmonary Pathology, awards are available to a limited number of individuals each year to defray some or all of the costs of travel to a meeting, training with a mentor, or ongoing collaborative study and research. 

Although the application is available to all members, preference in the award of support is given to pathologists in training (residents and / or fellows) or pathologists early in their career.

Interested individuals should fill out a PPS travel award grant application and send it, along with a copy of their curriculum vitae to Dr. Richard Attanoos, Chair of the PPS awards committee at This email address is being protected from spambots. You need JavaScript enabled to view it.. The application and CV should be submitted at least 3 months prior to the research / sabbatical / conference commencement date. Notification of decision on awards will be sent by email (or by post if email is unavailable)

pdfPPS Travel Award application127.95 KB


2017 PPS Travel Award

  • Deepali Jain, MD, Associate Professor, New Delhi , India 


PPS Lifetime Achievement Award

  • 2017: Tom Colby, MD
  • 2015: Andrew Churg, MD
  • 2013: Osama Matsubara, MD
  • 2011: Philip S. Hasleton, FRCPath
  • 2009: David Dail, MD
  • 2008: Bryan Corrin, MD 
  • 2007: Raymond Yesner, MD 
  • 2006: Anna-Louise Katzenstein, MD
  • 2005: S. Donald Greenberg, MD
  • 2004: James C. Hogg, M.D.
  • 2003: Victor J. Ferrans, M.D., Ph.D.


PPS Biennial Research Abstract Awards


1st Place

  • Adreanne Gagne, Universite Laval et Institute Universitaire de Cardiologie et de Pneumonologie de Quebec, Quebec City, Canada
    Comprehensive Assessment of PDL-1 Staining Heterogeneity and Expression by Histologic pattern of Pulmonary Adenocarcinoma: clinical implications

Commendation of Merit

  • Melanie Bois, Mayo Clinic Rochester
    Morphometric Study of Vascular Changes in Pulmonary Langerhans Cell Histiocytosis

  • Raghavendra Pillappa, Mayo Clinic Rochester
    Loss of BAP-1 Expression in Atypical Mesothelial Proliferations Helps to Predict Malignant Mesothelioma

2017 PPS Certificate of Appreciation

  • Robert McGonnagle
    In appreciation of Outstanding Contributions to the PPS


PPS Trainee Awards


1st Place

  • Peter Dromparis, University of Alberta
    Molecular Injury and Repair Assessment in Ex Vivo Perfused Swine Lung Transplants

2nd Place

  • Brandon Driver, Houston Methodist Hospital
    Discordant PD-L1 Expression in Non-Small Cell Lung Carcinoma Tissue Microarray Cores Compared to Corresponding Whole Tissue Sections
  • Patrice Desmeules, Memorial Sloan Kettering Cancer Center
    Metastatic Lung Carcinoid Tumors: Evidence of Proliferation Rate Progression at Metastatic Sites

3rd Place

  • Angela Shih, Massachusetts General Hospital
    Alveolar Framework Alterations in Fibrosing Interstitial Lung Disease: A Three-Dimensional Reconstruction Study
  • Lauren Rosen, University of Chicago
    Appropriate Use of Immunohistochemistry in the Diagnosis of Lung Cancer on Biopsy: A Retrospective Comparison from Four Academic Centers
  • Jonas Heymann, Columbia University Medical Center
    PD-L1 Expression in Non-Small Cell Lung Carcinoma (NSCLC): Feasibility of Cytology and Its Comparison with Resection and Small Biopsies



1st Place

  • Brandon S Sheffield, University of British Columbia, Vancouver, Canada; Phenopath, Seattle, WA
    Programmed Cell Death 1 Biomarker Testing: RNA and Protein Assessment

 2nd Place

  • Yalda B Naeini, UCLA, Los Angeles, CA; Clarient Pathology Services, Alisa Viejo, CA.
    Aggressive B-cell Lymphomas of the Respiratory System: Histologic, Immunohistochemical and Genetic Evaluation of a Large Series
  • Navin Madadevan,Brigham & Women’s Hospital, Boston, MA
    Non-Synonymous Mutation Burden in Lung Carcinoma Is Associated with Durable Clinical Response to Immune Checkpoint Blockade

3rd Place

  • Wadad Mneimneh, Mayo Clinic, Rochester, MN
    Pleuropulmonary Solitary Fibrous Tumors- A Clinicopathologic Study of 84 Cases with Comparison of Proposed Risk Stratification Systems
  • Angela R Shih, Massachusetts General Hospital
    Reproducibility in Classification of Small Lung Adenocarcinomas: An International Interobserver Study
  • Hamid Zia, New York Presbyterian Hospital – Weill Cornell Medical College, New York, NY 
    Comparison of Mutational Profiles in Cytology and Corresponding Surgical Specimens from Patients with Lung Adenocarcinoma



1st Place:

  • Brandon Sheffield, Vancouver General Hospital, Vancouver, British Columbia, Canada
    BAP1 Immunohistochemistry and p16 FISH To Separate Benign From Malignant Mesothelial Proliferations

2nd Place:

  • Olga Voronel, Albany Medical College, Albany, NY, United States
    Genomic Drivers of Pleural Malignant Mesothelioma Determined By Comprehensive Genomic Profiling: Opportunities for Targeted Therapies
  • Marina Vivero, Brigham and Women’s Hospital, Boston, MA, United States
    Clinicopathologic and Genetic Characteristics of Young Patients With Pleural Diffuse Malignant Mesothelioma

3rd Place:

  • Emilian Racila, Brigham and Women’s Hospital, Boston, MA, United States
    Squamous Cell Carcinoma Mutation Profile as a Tool to Distinguish Metastatic from Primary Lung Cancer
  • Akira Yoshikawa, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
    3D Pathology Construction Reveals Framework Structure of the Lung and Increase of Pores of Kohn as an Initial Event of Emphysema


  • Paula Ginter, Weill Cornell Medical College, New York, New York, United States; Rockefeller University, New York, NY, United States
    microRNA Sequencing Identified Frequent Shutdown of Chromosome 14q32 miRNA Cluster in Neuroendocrine Lung Carcinomas



1st Place: 

  • I Lamzabi, Rush University Medical Center, Chicago, IL
    Epigenetic Regulation of BAX Gene in Neuroendocrine Tumors of the Lung and Its Prognostic Implication

2nd Place: 

  • S Karimi, University Health Network, Toronto, CA
    Histological Patterns of Acute Lung Injury in Lung Transplant Patients with Restrictive Allograft Syndrome (RAS)
  • CP Hartley, Geisel School of Medicine, Dartmouth College, Hanover, NH
    Quantification of ALK from Formalin-Fixed Paraffin-Embedded Non-Small Cell Lung Cancer Tissue by Mass Spectrometry

3rd Place:

  • DH Hwang, Brigham and Women's Hospital, Boston, MA
    Next Generation Sequence Profiling of Large Cell Carcinoma / Solid Adenocarcinoma Defines Distinct Subgroups with Implications for Rational Therapy Selection
  • F Hamadeh, Cleveland Clinic, Cleveland, OH
    Clinicopathologic Features of Granulomatous-Lymphocytic Interstitial Lung Disease (GLILD) vs. Sarcoidosis
  • BC Willis, Emory University, Atlanta, GA
    c-Met Immunohistochemistry in EGFR Mutant Adenocarcinoma: Comparison with Fluorescence In-Situ Hybridization


Pathologist In Training Award

  • 2009-2010: Haresh Mani, MD, National Cancer Institute, NIH
  • 2008-2009: Lynette Sholl, MD, Brigham & Women’s Hospital
  • 2007-2008: Simion Chiosea, MD, University of Pittsburgh Medical Center
  • 2006-2007: Sanjay Mukhopadhyay, MD, State University of New York (SUNY) Upstate Medical University
  • 2005-2006: Noel A. Brownlee, MD, PhD, of Wake Forest University Baptist Medical Center, Winston-Salem, NC. Dr. Brownlee will study with  Victor Roggli of Duke University Medical Center
  • 2004-2005: Diana Ionescu, MD, University of Pittsburgh Medical Center and Harmanjatinder Sekhon, MD, PhD Oregon Health Sciences University, Portland, Oregon
  • 2001-2002 : Neil A. Abrahams of the Cleveland Clinic Foundation as recipient of the 2001-2002 Training Stipend Award.  Dr. Abrahams will receive a $1,750 stipend to spend a month studying lung pathology with Dr. Tom Colby at the Mayo Clinic, Scottsdale, Arizona.
  • 2000-2001 : Shuji Ogino, M.D., a Molecular Pathology Fellow at the University of Pennsylvania Medical Center.  Dr. Ogino will be studying pulmonary pathology with Dr. William Travis, Chair of the Department of Pulmonary and Mediastinal Pathology at the Armed Forces Institute of Pathology, Washington, D.C.
  • 1999-2000:Dra. Emilia Hernandez Nieto, Dpto Anatomia Patologica at Hospital Universitario "Marques de Valdecilla", Insituto Nacional de la Salud in Santander, Spain.